| Income Statement |
| Total Revenue | 773.73M |
|
| Revenues (USD) | 773.73M |
| Cost of Revenue | 433.49M |
| Gross Profit | 340.23M |
| Operating Expenses | 300.66M |
| Research and Development Expense | 11.19M |
| Selling, General and Administrative Expense | 289.47M |
| Operating Income | 39.57M |
| Income Tax Expense | 12.33M |
| Net Income | 29.21M |
| Net Income Common Stock | 29.21M |
| Net Income Common Stock (USD) | 29.21M |
| Consolidated Income | 29.21M |
| Earnings per Basic Share | 0.17 |
| Earnings per Basic Share (USD) | 0.17 |
| Earnings per Diluted Share | 0.16 |
| Earning Before Interest & Taxes (EBIT) | 41.54M |
| Earning Before Interest & Taxes (USD) | 41.54M |
| Weighted Average Shares | 176.84M |
| Weighted Average Shares Diluted | 179.46M |
| Balance Sheet |
| Cash and Equivalents | 344.22M |
| Cash and Equivalents (USD) | 344.22M |
| Trade and Non-Trade Receivables | 141.28M |
| Current Assets | 807.48M |
| Property, Plant & Equipment Net | 75.32M |
| Total Assets | 967.20M |
| Debt Current | 9.03M |
| Total Debt | 31.07M |
| Current Liabilities | 329.50M |
| Debt Non-Current | 22.04M |
| Total Liabilities | 357.51M |
| Accumulated Retained Earnings (Deficit) | 57.94M |
| Accumulated Other Comprehensive Income | 243.00K |
| Shareholders Equity | 609.69M |
| Shareholders Equity (USD) | 609.69M |
| Assets Non-Current | 159.72M |
| Total Debt (USD) | 31.07M |
| Goodwill and Intangible Assets | 53.14M |
| Inventory | 299.75M |
| Liabilities Non-Current | 28.01M |
| Trade and Non-Trade Payables | 263.86M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 5.42M |
| Net Cash Flow from Financing | -8.26M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 55.17M |
| Capital Expenditure | -9.26M |
| Issuance (Purchase) of Equity Shares | -3.62M |
| Net Cash Flow from Investing | -9.26M |
| Net Cash Flow from Operations | 72.58M |
| Effect of Exchange Rate Changes on Cash | 111.00K |
| Share Based Compensation | 7.94M |